Skip to content
Screener

Balchem BCPC Q1 2026 earnings

Reported April 30, 2026 · Before market open

Revenue$270.7MBeat by $4.2M
EPS$1.25Miss by $0.16
Revenue estimate$266.5M
EPS estimate$1.41

Next report

Oct 20, 2026 (in a month)
Revenue estimate$289.2M
EPS estimate$1.54

Financials

Q1 2026

Income statement

See full
Revenue$270.7M+8.1%
Gross profit$101.1M+14.6%
Operating income$55.6M+9.0%
Net income$40.3M+8.7%
EPS (diluted)$1.25+10.6%

Balance sheet

See full
Cash & equivalents$72.9M+46.0%
Total debt$37.4M-1.7%
Total equity$1.3B+6.3%
Total assets$1.7B+4.7%

Cash flow

See full
Operating cash flow$40.1M+9.9%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$5.43B+0.5%
Enterprise value$5.39B+0.1%
P/E34.3×-5.2×
P/S5.1×-0.5×

Profitability

See full
Gross margin36.3%+0.7pp
Operating margin20.2%+0.3pp
Net margin15%+0.8pp

Returns & leverage

See full
Return on equity12.7%+0.7pp
Debt / equity0×0.0×
Current ratio2.5×+0.1×

Segments

By segment

See full
Human Nutrition and Health$171.6M+8.3%
Animal Nutrition and Health$62.2M+8.6%
Specialty Products$34.7M+4.4%

FAQ

When did Balchem report Q1 2026 earnings?
Balchem (BCPC) reported Q1 2026 earnings on April 30, 2026 before market open.
What were Balchem's Q1 2026 revenue and EPS?
Balchem reported revenue of $270.7M and eps of $1.25 for Q1 2026.
Did Balchem beat estimates in Q1 2026?
Revenue beat the consensus estimate of $266.5M by $4.2M. EPS missed the consensus estimate of $1.41 by $0.16.
How did Balchem's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.1% from $250.5M a year earlier and eps grew 2.5% from $1.22.
Where can I find Balchem's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000009326-26-000016) and the 10-Q periodic report (0000009326-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.